SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277417
Filing Date
2023-11-15
Accepted
2023-11-15 06:04:32
Documents
15
Period of Report
2023-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891511d8k.htm   iXBRL 8-K 45204
2 EX-3.1 d891511dex31.htm EX-3.1 7282
3 EX-10.1 d891511dex101.htm EX-10.1 23674
  Complete submission text file 0001193125-23-277417.txt   271000

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA blacw-20231109.xsd EX-101.SCH 4237
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacw-20231109_def.xml EX-101.DEF 15403
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacw-20231109_lab.xml EX-101.LAB 26743
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacw-20231109_pre.xml EX-101.PRE 16416
9 EXTRACTED XBRL INSTANCE DOCUMENT d891511d8k_htm.xml XML 8949
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 231408951
SIC: 6770 Blank Checks